06.12.2012 Views

LEGIONELLA - World Health Organization

LEGIONELLA - World Health Organization

LEGIONELLA - World Health Organization

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

11.1.2 Staining<br />

Legionellae are Gram-negative bacteria with a thin cell wall, but stain poorly in the Gram<br />

procedure if neutral red or safranin is used as the counterstain. This characteristic is probably<br />

due to the composition of legionellae cell walls, which have large amounts of branched-chain<br />

cellular fatty acids and ubiquinones with side chains of 9–14 isoprene units (Moss et al., 1977;<br />

Lambert & Moss, 1989). Fatty acid and ubiquinone profiling have been used for identifying<br />

Legionella isolates to the level of species (Benson & Fields, 1998). On its own, Gram staining is<br />

inconclusive, even when samples are taken from normally sterile sites, such as transtracheal aspirates,<br />

lung biopsies or pleural fluids. Legionellae from these tissues appear as small, Gram-negative<br />

rods of varying sizes when counterstained with basic fuchsin. This effect is emphasized in legionellaeinfected<br />

tissues (Yu, 2000). Dieterle’s silver impregnation method is an alternative means of staining<br />

legionellae (Dieterle, 1927; Thomason et al., 1979). More sensitive and specific methods of<br />

identifying legionellae include antibody-coupled fluorescent dyes and immunoperoxidase staining.<br />

Further information on identifying legionellae species is given in Section 11.4.<br />

11.2 Diagnostic methods<br />

The clinical symptoms of infection with Legionella are indistinguishable from the symptoms<br />

of other causes of pneumonia. Accurate diagnostic methods are therefore needed to identify<br />

Legionella, and to provide timely and appropriate therapy. To improve diagnosis, specialized<br />

laboratory tests must be carried out, by the clinical microbiology laboratory, on patients in a<br />

high-risk category.<br />

Tests for Legionnaires’ disease should ideally be performed on all patients with pneumonia at risk,<br />

including those who are seriously ill (with or without clinical features of legionellosis), and those for<br />

whom no alternative diagnosis prevails. In particular, tests for Legionnaires’ disease should be carried<br />

out on ill patients who are older than 40 years, immunosuppressed or unresponsive to beta-lactam<br />

antibiotics, or who might have been exposed to Legionella during an outbreak (Bartlett et al., 1998).<br />

Despite the availability of immunological and molecular genetic methods, diagnosis of<br />

Legionnaires’ disease is generally effective only for L. pneumophila serogroup 1. The sensitivity and<br />

specificity of methods for diagnosing and identifying other L. pneumophila serogroups and<br />

species of Legionella are far from perfect (Tartakovsky, 2001).<br />

Since 1995, diagnostic tests for legionellosis have changed significantly. The following laboratory<br />

methods are currently used for diagnosing Legionella infections (Stout, Rihs & Yu, 2003):<br />

• isolation of the bacterium on culture media<br />

• identification of the bacterium using paired serology<br />

• detection of antigens in urine<br />

<strong>LEGIONELLA</strong> AND THE PREVENTION OF LEGIONELLOSIS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!